Pulmonary Adverse Events with Low-Dose Methotrexate

Refer to the full study for all source material.

Excerpted and adapted from:

Sparks JA, Dellaripa PF, Glynn RJ, et al. Pulmonary adverse events in patients receiving low-dose methotrexate in the randomized, double-blind, placebo-controlled cardiovascular inflammation reduction trial. Arthritis Rheumatol. 2020 Dec;72(12).